A
AN2 Therapeutics D
D
ANTX
1.12500
USD
-0.06
(-4.66%)
مغلق
حجم التداول
300
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
33,947,685
العنوان: AN2 Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.